Verónica Almeida-Marrero

Verónica Almeida-Marrero

Auto-generated profile, based on publicly available information

Verónica Almeida-Marrero

Department of Organic Chemistry / SIdI (MJVA) Universidad Autónoma de Madrid Campus de Cantoblanco 28049 Madrid Spain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2018 in Chemical Society Reviews
Verified
Journal Article
Open access
PDF file
VAVerónica Almeida-Marrero
Verónica Almeida-Marrero
EWEveline van de Winckel
Eveline van de Winckel
Eduardo Anaya PlazaEduardo Anaya Plaza
Eduardo Anaya Plaza
TTTomas Torres
Tomas Torres
AEAndres de la Escosura
Andres de la Escosura
The present article reviews the most important developing strategies in light-induced nanomedicine, based on the combination of porphyrinoid photosensitizers with a wide variety of biomolecules and biomolecular assemblies.

8 April 2021 in Chemistry – A European Journal
Verified
Journal Article
Open access
PDF file
VAVerónica Almeida‐Marrero
Verónica Almeida‐Marrero
Marta Mascaraque ChecaMarta Mascaraque Checa
Marta Mascaraque Checa
MVMaría Jesús Vicente‐Arana
María Jesús Vicente‐Arana
Angeles JuarranzAngeles Juarranz
Angeles Juarranz
TTTomas Torres
Tomas Torres
AEAndres de la Escosura
Andres de la Escosura
In the endeavor of extending the clinical use of photodynamic therapy (PDT) for the treatment of superficial cancers and other neoplastic diseases, deeper knowledge and control of the subcellular processes that determine the response of photosensitizers (PS) are needed. Recent strategies in this direction involve the use of activatable and nanostructured PS. Here, both capacities have been tuned in two dendritic zinc(II) phthalocyanine (ZnPc) derivatives, either asymmetrically or symmetrically substituted with 3 and 12 copies of the carbohydrate sialic acid (SA), respectively. Interestingly, the amphiphilic ZnPc‐SA biohybrid (1) self‐assembles into well‐defined nanoaggregates in aqueous solution, facilitating cellular internalization and transport whereas the PS remains inactive. Within the cells, these nanostructured hybrids localize in the lysosomes, as usually happens for anionic and hydrophilic aggregated PS. Yet, in contrast to most of them (e. g., compound2), hybrid1recovers the capacity for photoinduced ROS generation within the target organelles due to its amphiphilic character; this allows disruption of aggregation when the compound is inserted into the lysosomal membrane, with the concomitant highly efficient PDT response.